Niagen Bioscience, Inc.
Key Metrics
- Previous Close
- $1.87
- 52-Week Range
- $1.79 – $7.11
- Market Cap
- $145.72M
- P/E (TTM)
- 15.33
- EPS (TTM)
- 0.12
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.75
- PEG Ratio
- —
- Return on Equity
- 13.32%
- Return on Assets
- 1.69%
- Gross Margin
- 63.86%
- Operating Margin
- 2.28%
- Profit Margin
- 8.37%
- Current Ratio
- 5.93
- Debt/Equity
- 0.03
- Total Debt
- $2.08M
- Free Cash Flow
- $2.92M
- Revenue Growth
- -20.00%
- Earnings Growth
- —
- Enterprise Value
- $78.75M
Market Snapshot
About
Niagen Bioscience, Inc. is a biotechnology company focused on NAD+ precursor supplements and longevity research. The company develops and markets nicotinamide riboside-based products targeting cellular health and aging.